Te Ling
Impact in
-
- Acute Myeloid Leukemia Research
Papers in
- Genetics 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Hemoglobinopathies and Related Disorders 2
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- John D. Crispino (6 shared papers)Wei Tao (5 shared papers)Qiaoyun Zhu (4 shared papers)Wenbing Xie (4 shared papers)Ingrid Grummt (2 shared papers)Yonggang Zhou (2 shared papers)Weijun Feng (1 shared paper)Henk G. Stunnenberg (1 shared paper)
- Journals
- Blood (2 papers)Biochemical and Biophysical Research Communications (1 paper)Stem Cells (1 paper)Cancer Discovery (1 paper)Blood Advances (1 paper)
- Partner nations
- United StatesChinaPhilippines
In The Last Decade
Te Ling
12 papers receiving 400 citations
Peers
Comparison fields: 5 of 46
- Hematology 71
- Genetics 54
- Molecular Biology 311
- Cancer Research 26
- Genetics 52
Countries citing papers authored by Te Ling
This map shows the geographic impact of Te Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te Ling more than expected).
Fields of papers citing papers by Te Ling
This network shows the impact of papers produced by Te Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te Ling. The network helps show where Te Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Te Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 104 | |
| 2 | 2013 | 79 | |
| 3 | 2018 | 43 | |
| 4 | 2019 | 39 | |
| 5 | 2019 | 37 | |
| 6 | 2021 | 34 | |
| 7 | 2018 | 26 | |
| 8 | 2013 | 19 | |
| 9 | 2013 | 13 | |
| 10 | 2022 | 7 | |
| 11 | 2018 | 5 | |
| 12 | 2024 | 1 | |
| 13 | 2026 | 0 | |
| 14 | 2026 | 0 | |
| 15 | 2025 | 0 |
About Te Ling
Te Ling is a scholar working on Genetics, Hematology, Molecular Biology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 407 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Acute Myeloid Leukemia Research (4 papers), Epigenetics and DNA Methylation (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Genomics and Chromatin Dynamics (3 papers), RNA Research and Splicing (2 papers), Hemoglobinopathies and Related Disorders (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Hematology (71 citations), Genetics (54 citations), Molecular Biology (311 citations), Cancer Research (26 citations) and Genetics (52 citations). Te Ling has collaborated with scholars based in United States, China and Philippines. Frequent co-authors include John D. Crispino, Wei Tao, Qiaoyun Zhu, Wenbing Xie, Ingrid Grummt, Yonggang Zhou, Weijun Feng, Henk G. Stunnenberg, Le Zong and Guoliang Lyu. Their work appears in journals such as Blood, Biochemical and Biophysical Research Communications, Stem Cells, Cancer Discovery and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.